Glucanon Tablet 15 mg (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride
Prescription medication
Dong-A ST Co., Ltd.
MFDS item code 200707947 · Notified 2007.07.10
This product's status changed to Approval withdrawn on 2023.05.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication helps with blood sugar control in patients with type 2 diabetes. It can be used alone or in combination with sulfonylurea, metformin, or insulin if other blood sugar lowering agents are ineffective, while also following diet and exercise therapy. Additionally, nutritional counseling, weight loss, and regular exercise are essential to enhance treatment efficacy. It is effectively used to improve blood sugar control and health management in patients with type 2 diabetes.
Administer this medicine orally once daily, regardless of meals. As monotherapy, start with 15 mg once daily. If the effect is inadequate, the dose may be increased to 30 mg once daily. For combination therapy, administer 15 mg once daily. The maximum recommended dose is 30 mg once daily.
Use is not recommended in children under 18 years of age because there is no experience with its use in this age group.
This medication is used for the treatment of type 2 diabetes and plays a role in improving insulin resistance. It may cause or worsen congestive heart failure in some patients, so careful observation for symptoms of heart failure, weight changes, shortness of breath, and edema should be conducted after starting therapy. Patients with heart failure should not use this medication, and those with heart failure symptoms may need to discontinue or reduce the dosage. Since this medication can cause fluid retention and potentially worsen heart failure, it should be administered with caution in patients with a history of cardiovascular disease, hypertension, or myocardial infarction. This medication should not be given to patients with active bladder cancer or a history of bladder cancer, those with heart failure, liver impairment, severe renal impairment, type 1 diabetes, severe infections or trauma, or pregnant women. When combined with other oral hypoglycemic agents, the risk of hypoglycemia may increase, so caution is warranted, particularly when used with sulfonylureas or insulin. During treatment with this medication, adverse reactions such as edema, weight gain, headache, upper respiratory infections, myalgia, etc., may occur, and symptoms indicating liver dysfunction or visible hematuria and urination issues should be reported to a physician immediately. Women who are pregnant or may become pregnant should consult a specialist as taking this medication may affect the fetus, and those who are breastfeeding should determine its use according to a doctor's guidance. Elderly patients or those with impaired renal function should be closely monitored during treatment with this medication and should receive regular blood sugar and liver function tests. If symptoms such as sudden weight gain, shortness of breath, or edema occur during treatment, immediate medical attention should be sought, and the medication should be taken exactly as prescribed. Finally, this medication is not recommended for use in children as safety and efficacy have not been established.
Congestive heart failure, excessive and rapid weight change, shortness of breath, edema, fluid retention, inadequate blood sugar control, upper respiratory infection, headache, sinusitis, myalgia, pharyngitis, abdominal bloating, weight gain, hypoglycemia, urinary tract infection, back pain, dizziness, diarrhea, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, cardiovascular-related death, worsening of congestive heart failure, emergency room visits due to congestive heart failure, progression of congestive heart failure, hospitalization, liver failure, vision reduction, diabetic macular edema, decreased hemoglobin, decreased hematocrit, elevated serum ALT levels, elevated serum bilirubin levels, fractures, dizziness, loss of appetite, constipation, upper abdominal pain, chest pain, fatigue, weakness, dyspepsia, nausea, shortness of breath, itching, chest discomfort, tremors, chills, gastrointestinal disorders, abdominal pain, discomfort in the epigastric region, numbness, muscle rigidity, discomfort in the head, increased liver enzymes, worsening of liver disease, urticaria, eczema, arthralgia, knee abnormalities, arm weakness, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, weight gain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a special container to protect it from light, air, and moisture. The optimal storage temperature is between 15 and 30 degrees Celsius, and extremes of hot or cold should be avoided. Proper storage will help maintain the effectiveness of the medication for a long time.
White to gray-white, round, and convex tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Pioglitazone Hydrochloride
Prescription medication
Dong-A ST Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.